Caribou Biosciences regains Nasdaq minimum bid price compliance after 10-day period above $1.00

Caribou Biosciences, Inc.

Received Nasdaq compliance notice on June 18, 2025, confirming regained compliance with Listing Rule 5450(a)(1).
Closing bid price was $1.00 or greater for 10 consecutive trading days from June 3 to June 17, 2025.
Company had been at risk of delisting due to bid price deficiency; notice resolves that risk.
Company's common stock remains listed on the Nasdaq Global Select Market under ticker CRBU.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.